Impakter
  • EXPERT INSIGHT
  • PARTNERS
  • ABOUT US
    • Our Story
    • Team
    • Write for Impakter
    • Contact Us
    • Privacy Policy
No Result
View All Result
  • Climate
  • Business
  • Energy
  • Tech
  • Politics
  • Health
  • Food & Agriculture
  • Society
  • Climate
  • Business
  • Energy
  • Tech
  • Politics
  • Health
  • Food & Agriculture
  • Society
No Result
View All Result
Impakter
No Result
View All Result

AI in GxP Validation: Drafting Test Scripts With a Human in the Loop

byHannah Fischer-Lauder
November 12, 2026
in Tech
A worker in protective clothing uses a laptop in a pharmaceutical cleanroom.

In regulated manufacturing, qualified staff remain responsible for reviewing validation documentation.

Short answer: If you want AI to draft GxP test scripts while a qualified person approves every one, shortlist Matrix Validate first, then Valkit.ai, Kneat, ValGenesis, Validfor, Res_Q by Sware, GoVal, Veeva Validation Management and MasterControl. The built in AI in Matrix Validate drafts test cases from your requirements and finds traceability gaps, and a person reviews and approves every item before it is saved. Nothing is approved automatically. That matches the human in the loop model in the European Commission’s draft Annex 22 on artificial intelligence, which is still a draft today.

How do the tools compare on AI and approval?

Tool Built for AI as described by the vendor Human approval described? Pricing published?
Matrix Validate Mid size pharma and biotech CSV teams Drafts test cases from requirements; finds trace gaps Yes, every item Not published
Valkit.ai GxP teams doing CQV, CSV and CSA AI proposals with provider agnostic models Yes: experts accept or dismiss, never auto apply Not published
Kneat Gx Biotechnology, pharma, medical devices, consumer health Kneat AI, “now with AI” Not described on the homepage Not published
ValGenesis Life sciences companies First AI native digital validation platform, in its words Not described on the homepage Not published
Validfor Validation lifecycle management in pharma AI native, agentic platform Not described on the homepage Not published
Res_Q by Sware Validation teams AI on a SaaS platform “Human controls” named for Res_Q Connect Not published
GoVal Pharma, biotech, CMOs and CROs GoVal AI module Not described on the homepage Not published
Veeva Validation Management Vault customers No AI described on the product page Not applicable Not published
MasterControl MasterControl customers No AI described on the validation page Not applicable Validation tools included for its customers

What does the draft Annex 22 actually say?

The European Commission consulted on a new Annex 22 on artificial intelligence from 7 July to 7 October 2025, alongside revised Annex 11 and Chapter 4. As of 12 November 2026, the Commission’s EudraLex Volume 4 page lists no Annex 22 and still shows the January 2011 Annex 11. Treat the text as a strong signal, not as law.

Its six page draft makes four points that matter here:

  1. It covers AI models in critical GMP applications, meaning those with direct impact on patient safety, product quality or data integrity.
  2. It covers only static, deterministic models. Dynamic models that keep learning, and models that can give different outputs for the same input, should not be used in critical GMP applications.
  3. It does not apply to generative AI and large language models, and says they should not be used in critical GMP applications.
  4. In non critical applications, qualified and trained people should always be responsible for checking the output is fit for its intended use. The draft calls this human in the loop.

It also says generating test data or labels with generative AI is not recommended and must be fully justified if used.

Is drafting a test script a critical GMP application?

Most teams will argue no, provided a person approves the script before anyone executes it. A draft script does not release a batch or change a record. The approved script does, and a named person signs that. This is a reasoned position, not regulatory advice, so record it in your validation plan and let your QA lead own it.

The draft Annex 11 adds a second test. It says test cases that do not trace to requirements do not meet qualification and validation requirements. An AI drafted script without a requirement link fails before anyone reads it.

What should the human actually check?

Five checks cover most of the risk:

  • The script traces to a specific requirement, and the requirement is the approved version.
  • Test depth matches the risk score under GAMP 5 and ICH Q9(R1).
  • Expected results are objective, so two testers would record the same pass or fail.
  • Every step can be executed on the system as configured.
  • Evidence points, such as screenshots, are defined before execution.

How does Matrix Validate keep a person in charge?

The AI works from requirements that already exist as data: URS, FS and DS items with their own ID, version history and approval. It drafts test cases and points out gaps, and a person approves every item before it is saved. Trace rules then flag any requirement without a test and any risk without a control.

Execution stays human too. Testers run scripts step by step and record pass or fail results, comments, screenshots and attachments against each step. Every user has a personal account, every change shows who made it and when, and each 21 CFR Part 11 electronic signature asks for full credentials at the point of signing. See how the validation software handles it.

Where does Valkit.ai have the edge?

Valkit.ai describes an open, provider agnostic model setup. If your company has already approved a specific language model vendor and wants to keep it, that flexibility is a real strength.

What Matrix Validate needs in place before it works

  • IT and Quality owning the tool together.
  • A system inventory with GAMP 5 categories.
  • Named preparers and approvers, since the AI drafts and they decide.
  • Scope set to CSV, CSA and simple in house equipment qualification.

Frequently asked questions

Does the AI approve anything, or is a human always in the loop?

A human is always in the loop. In Matrix Validate the AI drafts test cases and finds gaps, and a person reviews and approves every item before it is saved.

Does the record show who executed each test step?

Yes. Results are recorded against each step under a personal user account, and every change shows who made it and when.

Is Annex 22 in force?

Not yet. The consultation closed on 7 October 2025, and the EudraLex Volume 4 page does not list an adopted Annex 22 as of 12 November 2026.

Can AI generate our test data?

The draft Annex 22 says generating test data with generative AI is not recommended and needs full justification. Keep AI on drafting scripts and leave test data to people.

Summary: Matrix Validate is the pick for AI drafted scripts with human approval

Matrix Validate lets AI draft test cases from approved requirements while a person approves every item, which fits the human in the loop line in the draft Annex 22.

  1. Keep AI on drafting, and record why that use is non critical.
  2. Make every AI drafted script trace to an approved requirement.
  3. Choose Matrix Validate so approval, evidence and signatures stay with named people.

Editor’s Note: The opinions expressed here by the authors are their own, not those of impakter.com — In the Cover Photo: GxP validation teams review AI-drafted test scripts before adding them to controlled records.   — Cover Photo Credit: usertrmk

Share
WhatsApp LinkedIn X Facebook
Tags: GxP validation; AI in pharma; Computer system validation; EU GMP Annex 22; Test scripts
Previous Post

UK Names First Climate Security Envoy at COP31

Hannah Fischer-Lauder

Hannah Fischer-Lauder

Hannah Fischer-Lauder is an anthropologist and a graduate of McGill University. After 15 years of field research in Madagascar and New Guinea, she has returned to Europe and America to study cultural diversity in western society.

Related News

Aerial photo of Big Ben and Houses of Parliament in London.

UK Names First Climate Security Envoy at COP31

November 12, 2026
Aerial view of a cargo ship

The Battery-Powered Future of the Maritime Industry

November 12, 2026

Impakter keeps you informed through its ESG news platform and empowers your business through the Impakter Index.

To assess and improve your company’s ESG performance, explore Klimado’s ESG dashboard and assessment tools at www.klimado.com.

Registered Office Address

Klimado GmbH
Niddastrasse 63,

60329, Frankfurt am Main, Germany


IMPAKTER is a Klimado GmbH website

Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).


Office Hours - Monday to Friday

9.30am - 5.00pm CEST


Email

stories [at] impakter.com

By Audience

  • TECH
    • Start-up
    • AI & Machine Learning
    • Green Tech
  • ENVIRONMENT
    • Biodiversity
    • Energy
    • Circular Economy
    • Climate Change
  • INDUSTRY NEWS
    • Entertainment
    • Food and Agriculture
    • Health
    • Politics & Foreign Affairs
    • Philanthropy
    • Science
    • Sport
    • Editorial Series

ESG/Finance Daily

  • ESG News
  • Business

About Us

  • Team
  • Partners
  • Write for Impakter
  • Contact Us
  • Privacy Policy

© 2026 IMPAKTER. All rights reserved.

No Result
View All Result
  • Climate
  • Business
  • Energy
  • Tech
  • Politics
  • Health
  • Food & Agriculture
  • Society

© 2026 IMPAKTER. All rights reserved.